Small Entity Compliance Guide: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims
- Docket Number:
- Issued by:
Guidance Issuing OfficeOffice of Nutrition and Food Labeling
For questions regarding this document, contact Julie Schrimpf at the Center for Food Safety and Applied Nutrition (CFSAN) at 240-402-2373.
The Food and Drug Administration (FDA) has prepared this Small Entity Compliance Guide in accordance with section 212 of the Small Business Regulatory Fairness Act (P.L. 104-121). This guidance document restates in plain language the legal requirements set forth in 21 CFR 101.9 and 101.36 concerning the declaration of trans fatty acids in the nutrition label of conventional foods and dietary supplements, respectively. These regulations are binding and have the force and effect of law. However, this guidance document represents FDA's current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternate approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.
On July 11, 2003, the Food and Drug Administration (FDA) published a final rule in the Federal Register that amended its regulations on food labeling to require that trans fatty acids be declared in the nutrition label of conventional foods and dietary supplements (68 FR 41434). This rule is effective January 1, 2006.
FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.
What are fatty acids?
Fatty acids are the chemical compounds that make up fats. Fatty acids are chains of carbon atoms with hydrogen atoms attached to the carbon atoms. A "saturated" fatty acid has the maximum possible number of hydrogen atoms attached to every carbon atom. It is therefore said to be "saturated" with hydrogen atoms.
Sometimes a pair of hydrogen atoms in the middle of a chain is missing, creating a gap that leaves two carbon atoms connected by a double bond, rather than a single bond. The missing hydrogen atoms cause the chain to be "unsaturated." A fatty acid that has one double bond is said to be "monounsaturated." Fatty acids having more than one double bond are called "polyunsaturated." Usually, the hydrogen atoms at a double bond are positioned on the same side of the carbon chain. In fact, all fatty acids listed as "monounsaturated" and "polyunsaturated" in nutrition labeling are of this type (i.e., in the "cis" configuration).
The structure of saturated and unsaturated chemical bonds is represented in the diagram below.
What are trans fatty acids?
Trans fatty acids, also known as trans fats, are made during partial hydrogenation of vegetable oils. Hydrogenation is the process by which hydrogen atoms are added to unsaturated sites on fatty acids, thereby, eliminating double bonds. Partial hydrogenation relocates some double bonds and hydrogen atoms end up on different sides of the chain. This type of configuration is called "trans" (means "across" in Latin).
The structure of a trans unsaturated chemical bond is represented in the diagram below.
Why is FDA requiring that trans fatty acids be listed in nutrition labeling?
FDA is requiring that trans fatty acids be listed in nutrition labeling in response to a petition from the Center for Science in the Public Interest and to published human studies that show that intake of trans fatty acids, similar to the intake of saturated fatty acids, increases low density lipoprotein-cholesterol (LDL-C) ("bad cholesterol") in the blood. An elevated LDL-C increases the risk of developing coronary heart disease. Reports published by the Institute of Medicine of the National Academy of Sciences (IOM/NAS) and the Federal government have recommended that Americans limit their intake of trans fat and other cholesterol-raising fats while consuming a nutritionally adequate diet. For Americans to follow these recommendations, they must know the amount of trans fatty acids in the individual foods that they eat. Therefore, FDA is requiring that this information be provided in nutrition labeling to assist consumers in maintaining healthy dietary practices.
Do trans fatty acids need to be listed when mono- and polyunsaturated fatty acids are not listed?
Yes. The listing of trans fatty acids is mandatory even when mono- and polyunsaturated fatty acids are not listed.
How should trans fatty acids be listed?
Trans fatty acids should be listed as "Trans fat" or "Trans" on a separate line under the listing of saturated fat in the nutrition label. Trans fat content must be expressed as grams per serving to the nearest 0.5-gram increment below 5 grams and to the nearest gram above 5 grams. If a serving contains less than 0.5 gram, the content, when declared, must be expressed as "0 g."
If a serving contains less than 0.5 gram of trans fat, when would "0 g" of trans fat not have to be declared?
For conventional food products (those food products other than dietary supplements), declaration of "0 g" of trans fat is not required for such products that contain less than 0.5 g of total fat in a serving if no claims are made about fat, fatty acid or cholesterol content. In the absence of these claims, the statement "Not a significant source of trans fat" may be placed at the bottom of the table of nutrient values in lieu of declaring "0 g" of trans fat.
The labeling of dietary supplements is different than the labeling of conventional foods. Certain nutrients in conventional foods, when not present or when present at levels that the agency has determined to be "zero" (see 21 CFR 101.9(c)), must be listed as zero on conventional food labels. However, when those same nutrients are not present in dietary supplements or present in dietary supplements at levels that the agency has determined, for conventional foods, to be "zero," such nutrients must not be listed on dietary supplement labels. Amounts of "0 g" and "Not a significant source..." statements are not allowed in the nutrition labeling of dietary supplements (i.e., Supplement Facts). Consequently, when the amount of trans fat in a dietary supplement is less than 0.5 gram per serving, trans fat must not be listed on the Supplement Facts panel.
What should be listed as the "% DV" for trans fat?
FDA recommends that you leave this blank. No percent is shown because there is no Daily Value for trans fatty acids
Is the footnote "Intake of trans fat should be as low as possible" required?
No. A footnote of this type is not required. The IOM/NAS report recommended that "trans fat consumption be as low as possible while consuming a nutritionally adequate diet." Shortly after the issuance of this report, FDA proposed the use of an explanatory footnote, "Intake of trans fat should be as low as possible." However, we received very negative comments on the wording of this footnote. As a result, FDA is conducting consumer studies and has issued an advance notice of proposed rulemaking (ANPR) on this issue (68 FR 41507; July 11, 2003). In the ANPR, FDA is soliciting data and information on the effectiveness of various footnotes, including those that address saturated fat and cholesterol in addition to trans fatty acids. Consequently, there is no regulation allowing the use of a footnote at this time.
Will the content of total fat be changed?
No, because trans fat is already included in the amount declared for "Total Fat."
Does the final rule change the regulations dealing with nutrient content or health claims?
No. The sections of the November 17, 1999 proposal (64 FR 62746) dealing with nutrient content and health claims are being withdrawn. The agency is asking for comment and data, in an ANPR (referenced above in response to question #8), that could assist the agency in a future rulemaking when considering trans fat levels in nutrient content and health claims.
Can trans fatty acids be labeled right now?
When does this rule become effective?
The effective date of this final rule is January 1, 2006. Starting on this date, food labels, including those for certain dietary supplements, must include trans fat in nutrition labeling on products being introduced into interstate commerce.
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2013-S-0610.